<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72305">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02055742</url>
  </required_header>
  <id_info>
    <org_study_id>MBI-01-CTNG</org_study_id>
    <secondary_id>Meridian Bioscience, Inc.</secondary_id>
    <nct_id>NCT02055742</nct_id>
  </id_info>
  <brief_title>Detection of Chlamydia (CT) and Gonorrhea (NG)</brief_title>
  <official_title>Clinical Study Protocol for the Illumigene® Chlamydia and Illumigene® Gonorrhea DNA Amplification Assays</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meridian Bioscience, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meridian Bioscience, Inc.</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the illumigene Chlamydia and illumigene Gonorrhea assays, using the
      illumipro-10, with  male urine, female urine, physician-collected (medical professional)
      endocervical swabs and self-collected vaginal swabs taken from symptomatic and asymptomatic
      patient populations.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">August 2014</completion_date>
  <primary_completion_date type="Anticipated">August 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Qualitative detection of Chlamydia trachomatis and/or Neisseria gonorrhoeae (GC) to aid in the diagnosis of chlamydial and/or gonococcal urogenital disease</measure>
    <time_frame>Up to 60 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Testing of each set of subject samples is completed within 60 days of sample collection</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">6600</enrollment>
  <condition>Chlamydia</condition>
  <condition>Gonorrhea</condition>
  <arm_group>
    <arm_group_label>Specimen Collection</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>illumigene CT and NG assays, illumipro-10</intervention_name>
    <arm_group_label>Specimen Collection</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Leftover urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Symptomatic and asymptomatic subjects at least 14 years of age
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female

          2. Any ethnicity or race

          3. Subject &gt;14 and &lt;89 years of age

          4. Subject who voluntarily gives written informed consent

          5. Symptomatic or asymptomatic subject who is able and willing to provide the required
             urine and swab samples for testing for CT and NG

        Exclusion Criteria:

          1. Subjects &lt; 14 or &gt;90 years of age

          2. Subjects who are unwilling to sign the written informed consent

          3. Subject who is unwilling or unable to provide the required urine and swab samples for
             testing

          4. Individuals who have been on antibiotic medications within 10 days.

          5. Multiple sets of specimens from the same subject at different office visits

          6. Samples collected or processed in manner other than specified in the study protocol
             and Investigational Use Only package insert.

          7. Frozen archived specimens
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>New England Center for Clinical Research</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Bergeron</last_name>
      <phone>508-672-7450</phone>
    </contact>
    <investigator>
      <last_name>Stephen Kasperian, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Planned Parenthood Southeastern PA</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Illona Feldman, MA</last_name>
      <phone>267-514-2098</phone>
      <email>illona.feldman@ppsp.org</email>
    </contact>
    <investigator>
      <last_name>Joel Lebed, D.O.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 27, 2014</lastchanged_date>
  <firstreceived_date>January 31, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chlamydia Infections</mesh_term>
    <mesh_term>Gonorrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
